HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat
Authors
Keywords
-
Journal
Chemical Science
Volume 7, Issue 3, Pages 2353-2358
Publisher
Royal Society of Chemistry (RSC)
Online
2016-01-05
DOI
10.1039/c5sc03257a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patients
- (2015) Anne Sofie Høgh Kølbæk Kjær et al. AIDS
- Understanding HIV Latency: The Road to an HIV Cure
- (2015) Matthew S. Dahabieh et al. Annual Review of Medicine
- Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs
- (2015) Camilla Frich Riber et al. Advanced Healthcare Materials
- Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs
- (2014) Anders Kock et al. CHEMICAL COMMUNICATIONS
- Polymer therapeutics: Top 10 selling pharmaceuticals — What next?
- (2014) Ruth Duncan JOURNAL OF CONTROLLED RELEASE
- Highly Active Macromolecular Prodrugs Inhibit Expression of the Hepatitis C Virus Genome in the Host Cells
- (2014) Pau Ruiz-Sanchis et al. Advanced Healthcare Materials
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Narrow Therapeutic Window of Ribavirin as an Inhibitor of Nitric Oxide Synthesis is Broadened by Macromolecular Prodrugs
- (2013) Benjamin M. Wohl et al. BIOMACROMOLECULES
- An Integrated Overview of HIV-1 Latency
- (2013) Debbie S. Ruelas et al. CELL
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Comparison of HDAC inhibitors in clinical development
- (2013) Thomas Aagaard Rasmussen et al. Human Vaccines & Immunotherapeutics
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- Living Radical Polymerization by the RAFT Process ? A Third Update
- (2012) Graeme Moad et al. AUSTRALIAN JOURNAL OF CHEMISTRY
- Tenofovir, Emtricitabine Intracellular and Plasma, and Efavirenz Plasma Concentration Decay Following Drug Intake Cessation
- (2012) Akil Jackson et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
- (2012) Daniel I S Rosenbloom et al. NATURE MEDICINE
- Self-immolative linkers in polymeric delivery systems
- (2010) Christopher A. Blencowe et al. Polymer Chemistry
- HPMA copolymers: Origins, early developments, present, and future☆
- (2009) Jindřich Kopeček et al. ADVANCED DRUG DELIVERY REVIEWS
- Synthesis of Functional Polymers by Post-Polymerization Modification
- (2008) Marc A. Gauthier et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Prodrug Strategies in Anticancer Chemotherapy
- (2007) Felix Kratz et al. ChemMedChem
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started